Cargando…

3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications

With a limited supply of organ donors and available organs for transplantation, the aim of tissue engineering with three-dimensional (3D) bioprinting technology is to construct fully functional and viable tissue and organ replacements for various clinical applications. 3D bioprinting allows for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Earnest P., Toksoy, Zeren, Davis, Bruce A., Geibel, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158943/
https://www.ncbi.nlm.nih.gov/pubmed/34055761
http://dx.doi.org/10.3389/fbioe.2021.664188
_version_ 1783699974876299264
author Chen, Earnest P.
Toksoy, Zeren
Davis, Bruce A.
Geibel, John P.
author_facet Chen, Earnest P.
Toksoy, Zeren
Davis, Bruce A.
Geibel, John P.
author_sort Chen, Earnest P.
collection PubMed
description With a limited supply of organ donors and available organs for transplantation, the aim of tissue engineering with three-dimensional (3D) bioprinting technology is to construct fully functional and viable tissue and organ replacements for various clinical applications. 3D bioprinting allows for the customization of complex tissue architecture with numerous combinations of materials and printing methods to build different tissue types, and eventually fully functional replacement organs. The main challenge of maintaining 3D printed tissue viability is the inclusion of complex vascular networks for nutrient transport and waste disposal. Rapid development and discoveries in recent years have taken huge strides toward perfecting the incorporation of vascular networks in 3D printed tissue and organs. In this review, we will discuss the latest advancements in fabricating vascularized tissue and organs including novel strategies and materials, and their applications. Our discussion will begin with the exploration of printing vasculature, progress through the current statuses of bioprinting tissue/organoids from bone to muscles to organs, and conclude with relevant applications for in vitro models and drug testing. We will also explore and discuss the current limitations of vascularized tissue engineering and some of the promising future directions this technology may bring.
format Online
Article
Text
id pubmed-8158943
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81589432021-05-28 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications Chen, Earnest P. Toksoy, Zeren Davis, Bruce A. Geibel, John P. Front Bioeng Biotechnol Bioengineering and Biotechnology With a limited supply of organ donors and available organs for transplantation, the aim of tissue engineering with three-dimensional (3D) bioprinting technology is to construct fully functional and viable tissue and organ replacements for various clinical applications. 3D bioprinting allows for the customization of complex tissue architecture with numerous combinations of materials and printing methods to build different tissue types, and eventually fully functional replacement organs. The main challenge of maintaining 3D printed tissue viability is the inclusion of complex vascular networks for nutrient transport and waste disposal. Rapid development and discoveries in recent years have taken huge strides toward perfecting the incorporation of vascular networks in 3D printed tissue and organs. In this review, we will discuss the latest advancements in fabricating vascularized tissue and organs including novel strategies and materials, and their applications. Our discussion will begin with the exploration of printing vasculature, progress through the current statuses of bioprinting tissue/organoids from bone to muscles to organs, and conclude with relevant applications for in vitro models and drug testing. We will also explore and discuss the current limitations of vascularized tissue engineering and some of the promising future directions this technology may bring. Frontiers Media S.A. 2021-05-13 /pmc/articles/PMC8158943/ /pubmed/34055761 http://dx.doi.org/10.3389/fbioe.2021.664188 Text en Copyright © 2021 Chen, Toksoy, Davis and Geibel. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Chen, Earnest P.
Toksoy, Zeren
Davis, Bruce A.
Geibel, John P.
3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications
title 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications
title_full 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications
title_fullStr 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications
title_full_unstemmed 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications
title_short 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications
title_sort 3d bioprinting of vascularized tissues for in vitro and in vivo applications
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158943/
https://www.ncbi.nlm.nih.gov/pubmed/34055761
http://dx.doi.org/10.3389/fbioe.2021.664188
work_keys_str_mv AT chenearnestp 3dbioprintingofvascularizedtissuesforinvitroandinvivoapplications
AT toksoyzeren 3dbioprintingofvascularizedtissuesforinvitroandinvivoapplications
AT davisbrucea 3dbioprintingofvascularizedtissuesforinvitroandinvivoapplications
AT geibeljohnp 3dbioprintingofvascularizedtissuesforinvitroandinvivoapplications